2025-08-25 - Analysis Report
Okay, here's a report summarizing the analysis of Intuitive Surgical Inc. (ISRG), incorporating the provided data.

## Intuitive Surgical Inc. (ISRG) Analysis

**Company Overview:** Intuitive Surgical Inc. designs, manufactures, and markets the da Vinci surgical system and related instruments and accessories.

### 1. Performance vs. S&P 500 (VOO)

*   **ISRG Cumulative Return:** 111.11%
*   **VOO Cumulative Return:** 38.83%
*   **Absolute Spread:** 72.28%

**Relative Spread Analysis:**

*   **Max Spread:** 127.7
*   **Min Spread:** -6.8
*   **Current Spread:** 13.8
*   **Relative Spread Position:** 15.3 (Indicates the current spread is at the 15.3rd percentile of its historical range)

**Analysis:** ISRG has significantly outperformed the S&P 500 (VOO) over the period examined. However, the *Relative Spread Position* suggests that while ISRG is currently outperforming, the magnitude of outperformance is relatively low compared to its historical peak outperformance.

**Alpha, Beta & Performance Metrics:**

| Year      | CAGR     | MDD      | Alpha   | Beta   | Cap(B) |
| :---------- | :------- | :------- | :------ | :----- | :----- |
| 2015-2017 | 68.0%    | 56.5%    | 68.0%   | 1.0    | 43.6  |
| 2016-2018 | 77.0%    | 63.4%    | 77.0%   | 1.0    | 57.2  |
| 2017-2019 | 81.0%    | 63.4%    | 81.0%   | 1.0    | 70.6  |
| 2018-2020 | 47.0%    | 63.4%    | 47.0%   | 1.0    | 97.8  |
| 2019-2021 | 91.0%    | 63.0%    | 90.0%   | -0.0   | 128.8 |
| 2020-2022 | -3.0%    | 69.9%    | 7.0%    | -0.1   | 95.1  |
| 2021-2023 | -5.0%    | 72.9%    | -15.0%  | -0.0   | 120.9 |
| 2022-2024 | 26.0%    | 72.9%    | -4.0%   | -0.0   | 187.1 |
| 2023-2025 | 32.0%    | 72.9%    | -13.0%  | 0.0    | 170.7 |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** High CAGRs in the earlier periods indicate strong historical growth. More recent periods (2020-2025) show decreased or negative growth.
*   **MDD (Maximum Drawdown):** Consistently high MDD values suggest significant volatility and risk.
*   **Alpha:** Positive Alpha values in earlier periods indicate outperformance relative to the market. More recent periods show negative Alpha, meaning underperformance relative to the market.
*   **Beta:** Beta near 1.0 in earlier periods suggests ISRG moved in line with the market. More recent periods show Beta near 0, indicating little correlation with the market.
*   **Cap(B) (Market Capitalization in Billions):** The increasing market cap reflects the company's growth over time.

### 2. Recent Stock Price Movements

*   **Current Price:** 476.16
*   **Last Market Data:** Price Change of 1.34 from previousClose 469.88
*   **5-day Moving Average:** 477.394
*   **20-day Moving Average:** 480.3275
*   **60-day Moving Average:** 510.971

**Analysis:**

*   The current price is slightly below the 5-day and 20-day moving averages, and significantly below the 60-day moving average. This suggests a potential short-term downward trend.
*   The positive price change suggests a small rebound, but the moving averages indicate that the price may need to rise further to confirm a trend reversal.
*  The positive price change of 1.34 indicates a modest upward movement in the stock's price from the previous day's closing, suggesting potential short-term positive momentum.

### 3. Technical Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.3377 (Low Risk)
*   **RSI:** 43.54 (Neutral - Neither overbought nor oversold)
*   **PPO:** 0.2572
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (8 shares - Safe - MRI:0.33)
*   **20-day Relative Spread Change:** 1.5 (+) (Short-term increase)
*   **Expected Return:** 236.4% (Long-term, relative to S&P 500)

**Analysis:**

*   The MRI indicates low market risk, which is a positive sign.
*   The RSI suggests the stock is not currently overbought or oversold.
*   The positive change in relative spread suggests the stock has been outperforming the S&P 500 recently.
*   The very high expected return suggests significant potential upside over the long term, relative to the S&P 500.

### 4. Recent News & Significant Events

*   **[2025-08-21]** Major business developments, regulatory changes, or market events.
*   **[2025-08-22]** Analyst discussion of performance and outlook within industry trends and global economic factors.
*   **[2025-08-23]** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-08-24]** Market experts highlight both risks and opportunities; investors advised to monitor news and announcements.

**Analysis:** The news suggests potential significant events impacting ISRG, leading to volatility and requiring careful monitoring of further developments.

### 5. Recent Earnings Analysis

| 날짜         | EPS  | 매출       |
| :----------- | :--- | :--------- |
| 2025-07-23 | 1.84 | 2.44 B$    |
| 2025-04-23 | 1.95 | 2.25 B$    |
| 2024-10-18 | 1.59 | 2.04 B$    |
| 2024-07-19 | 1.48 | 2.01 B$    |
| 2025-07-23 | 1.48 | 2.01 B$    |

**Analysis:**

*   EPS and revenue have generally been increasing over the last few quarters, indicating growth in the company's profitability.
*   The most recent quarter (2025-07-23) shows a slight decrease in EPS compared to the previous quarter but a significant increase in revenue.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| :----------- | :-------- | :------------ |
| 2025-06-30 | $2.44B    | 66.31%        |
| 2025-03-31 | $2.25B    | 64.69%        |
| 2024-12-31 | $2.41B    | 68.04%        |
| 2024-09-30 | $2.04B    | 67.41%        |
| 2024-06-30 | $2.01B    | 68.30%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
| :----------- | :-------- | :----- |
| 2025-06-30 | $17.85B   | 3.69%  |
| 2025-03-31 | $17.11B   | 4.08%  |
| 2024-12-31 | $16.43B   | 4.17%  |
| 2024-09-30 | $15.58B   | 3.63%  |
| 2024-06-30 | $14.71B   | 3.58%  |

**Analysis:**

*   **Revenue and Profitability:** Revenue has been consistently growing, and profit margins remain very healthy, indicating strong business performance.
*   **Capital and Profitability:** Equity is increasing, reflecting the company's growth. ROE (Return on Equity) fluctuates, but remains at healthy levels.

### 7. Overall Summary

Intuitive Surgical (ISRG) demonstrates strong historical growth, but recent data suggests a possible short-term slowdown or correction.

*   **Strengths:**
    *   Significant historical outperformance vs. S&P 500.
    *   Strong revenue and profit margins.
    *   Low Market Risk Indicator.
    *   High long-term expected return (relative to S&P 500).

*   **Weaknesses/Concerns:**
    *   Recent underperformance relative to the market (negative Alpha).
    *   High Maximum Drawdown indicates volatility.
    *   Recent price action below moving averages suggests a potential downward trend.
    *   News indicating potential volatility and significant developments.

*   **Investment Recommendation:**

The "Hybrid Signal" gives a buy signal, and the low Market Risk Indicator (MRI) gives us safety signals, which may be useful for investment reference.
**Despite the recent challenges, the long-term outlook for ISRG appears positive, particularly given the high expected return. However, investors should carefully monitor the news, upcoming earnings reports, and price action to assess the short-term risks and opportunities. A long-term accumulation strategy might be suitable, but caution is advised in the short term.**
